Coronavirus Contracts

Donate
Contracts Vendors Agencies Categories States
Coronavirus Contracts
Tracking Federal Purchases to Fight the Coronavirus
Search contract descriptions, companies and agencies.
Home › All Categories › Category ›
Biomedical Applied Research/Exploratory Development R&D
Total Committed Value of Federal Contracts
$839M
Total Contracts
67
Total Actions
188

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description Vendor Agency Effective Estimated completion Amount Committed
LARGE SCALE T CELL EPITOPE DISCOVERY LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY National Institutes of Health September 30, 2019 September 29, 2024 $300,000
COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. National Institutes of Health September 10, 2019 September 09, 2022 $0
NIAID VRC LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $500,000
TO SUPPORT ON-GOING STUDIES OF THE EMERGING SARS-COV-2 VARIANTS, SUCH AS HOW THE SPIKE PROTEIN FROM THE VARIANTS OF CONCERN INTERACT WITH ANTIBODIES. SEATTLE CHILDREN'S HOSPITAL National Institutes of Health July 27, 2017 August 31, 2022 $311,000
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $8,758,455
NIAID DIR LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $1,100,000
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI National Institutes of Health January 09, 2014 August 01, 2022 $1,839,820
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER). CHROMOLOGIC LLC National Institutes of Health February 28, 2017 May 10, 2022 $0
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST DUKE UNIVERSITY National Institutes of Health September 10, 2019 July 31, 2022 $515,384
NATIONAL HISTORY OF SARS-COV-2 INFECTION REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE Centers for Disease Control and Prevention June 01, 2020 November 30, 2022 $240,714
AWARD OF THE BASE TO ST. JUDE FOR CEIRR CONTRACT 75N93021C00016. THIS CONTRACT WILL SUPPORT NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR). ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. National Institutes of Health April 01, 2021 March 31, 2022 $8,992,234
NIAID DIVISION OF ALLERGY, IMMUNOLOGY & TRANSPLANTATION: IMMUNE MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC) EMINENT SERVICES CORPORATION National Institutes of Health April 01, 2019 March 31, 2026 $91,235
AWARD OF THE BASE TO UPENN FOR CEIRR CONTRACT 75N93021C00015. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE National Institutes of Health April 01, 2021 March 31, 2022 $6,984,256
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID COMMUNITY ACTION AND RESEARCH ENGAGEMENT (COVID-CARE) VIGNET INC. National Institutes of Health September 14, 2020 September 13, 2021 $2,927,659
MSSM CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI National Institutes of Health April 01, 2021 March 31, 2022 $6,001,311
UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. National Institutes of Health April 01, 2021 March 31, 2022 $1,000,000
ESTABLISH A VIRTUAL NETWORK TO INVESTIGATE THE TRAJECTORY OF COVID-19-RELATED SEVERE OUTCOMES WESTAT, INC. Centers for Disease Control and Prevention May 04, 2020 September 30, 2022 $2,738,185
MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC)FOR RAPID RESPONSE TO COVID-19 PANDEMIC UNIVERSITY OF CHICAGO, THE National Institutes of Health August 21, 2020 August 20, 2022 -$155,424
MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC UNIVERSITY OF CHICAGO, THE National Institutes of Health August 21, 2020 August 20, 2022 $0
CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATES BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $0
NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID COMMUNITY ACTION AND RESEARCH ENGAGEMENT (COVID-CARE) VIGNET INC. National Institutes of Health September 14, 2020 September 13, 2021 $0
CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $86,551,385
CLINICAL SAMPLE TESTING FOR SARS-COV-2 VACCINE CANDIDATES BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $0
HHSN275201800008I/HHSN27500001 - POPULATION HEALTH RESEARCH SUPPORT/ TASK ORDER STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) - DUKE UNIVERSITY - CAN 8473518 DUKE UNIVERSITY National Institutes of Health September 09, 2019 March 08, 2022 $0
COVID-19 RESEARCH NATIONAL OPINION RESEARCH CENTER Centers for Disease Control and Prevention February 01, 2021 August 01, 2021 $42,509
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID COMMUNITY ACTION AND RESEARCH ENGAGEMENT (COVID-CARE) VIGNET INC. National Institutes of Health September 14, 2020 September 13, 2021 $0
DIGITAL HEALTH SOLUTIONS FOR COVID-19: DIGITAL HEALTH PASS AND SMARTER CONTACT TRACING SOLUTIONS INTERNATIONAL BUSINESS MACHINES CORPORATION National Institutes of Health September 14, 2020 September 13, 2021 $0
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $777,104
NIAID COVID-19 ACTIV3 LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 -$7,368,816
NIAID DMID BIG EFFECT TRIAL (BET) - INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED A MULTICENTER PLATFORM EVALUATING PUTATIVE THERAPEUTICS FOR THE TREATMENT OF COVID-19 IN HOSPITALIZED ADULTS (SHORT TITLE, LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19". LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $25,075,500
NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID COMMUNITY ACTION AND RESEARCH ENGAGEMENT (COVID-CARE) VIGNET INC. National Institutes of Health September 14, 2020 September 13, 2021 $0
DIGITAL HEALTH SOLUTIONS FOR COVID-19 SHEE ATIKA ENTERPRISES, LLC National Institutes of Health September 14, 2020 September 13, 2021 $2,711,605
EXERCISE OPTION FOR PHASE II - DIGITAL HEALTH SOLUTIONS FOR COVID-19: PERSONALIZED ANALYTICS WEARABLE BIOSENSOR PLATFORM FOR EARLY DETECTION OF COVID-19 DECOMPENSATION PHYSIQ, INC National Institutes of Health September 14, 2020 September 13, 2021 $4,338,693
COVID-19: NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT DUKE UNIVERSITY National Institutes of Health December 22, 2017 December 17, 2024 $517,711
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID-19 ONGOING MONITORING (COMMUNITY) EVIDATION HEALTH, INC. National Institutes of Health September 14, 2020 September 13, 2021 $0
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID-19 ONGOING MONITORING (COMMUNITY) EVIDATION HEALTH, INC. National Institutes of Health September 14, 2020 September 13, 2021 $560,000
DIGITAL HEALTH SOLUTIONS FOR COVID-19: CLEAR2GO ICRYPTO, INC. National Institutes of Health September 14, 2020 September 13, 2021 $1,524,610
LARGE SCALE T CELL EPITOPE DISCOVERY LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY National Institutes of Health September 30, 2019 September 29, 2024 $299,928
COVID-19 RELATED WORK - CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) FISHER BIOSERVICES INC. National Institutes of Health June 16, 2020 June 15, 2027 $514,470
IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST EMERGING INFECTIOUS DISEASES INCLUDING COVID-19 (SARS-C0V2) BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $1,064,710
DIGITAL HEALTH SOLUTIONS FOR COVID-19: CLEAR2GO ICRYPTO, INC. National Institutes of Health September 14, 2020 September 13, 2021 $0
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
"COVID-19 RELATED WORK" - THE PURPOSE OF THE EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL) IS TO PROVIDE CONFIDENCE THAT INDIVIDUAL LABORATORIES GENERATE RELIABLE DATA TO SUPPORT VACCINE IMMUNOGEN ADVANCEMENT. DUKE UNIVERSITY National Institutes of Health August 29, 2017 September 29, 2024 $613,865
DIGITAL HEALTH SOLUTIONS FOR COVID-19: DIGITAL HEALTH PASS AND SMARTER CONTACT TRACING SOLUTIONS INTERNATIONAL BUSINESS MACHINES CORPORATION National Institutes of Health September 14, 2020 September 13, 2021 $4,135,490
DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $252,370
IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST EMERGING INFECTIOUS DISEASES INCLUDING COVID-19 (SARS-C0V2) BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $0
PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) SEATTLE CHILDREN'S HOSPITAL National Institutes of Health September 30, 2019 September 29, 2026 $0
TO ADD FUNDS IN THE AMOUNT OF $18,272.22 TO COVER AN FY18 INDIRECT RATE INCREASE AND UPDATE FAR CLAUSES 52.204-24 AND 52.204-25. HEALTH DECISIONS, INC. National Institutes of Health July 18, 2017 July 17, 2022 $18,272
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS). ST. JUDE CHILDREN'S RESEARCH HOSPITAL National Institutes of Health January 09, 2014 May 20, 2022 $0
BPCA PHARMACOLOGY STUDIES (TO2)- PERIOD OF PERFORMANCE: 9/14/18 - 9/13/22 DUKE UNIVERSITY National Institutes of Health September 11, 2018 September 13, 2022 $0
NIAID DCR OPERATIONAL COVID RELATED EFFORTS LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
ON BEHALF OF DCR FACILITATE THE CONDUCT OF AN OBSERVATIONAL STUDY TO CHARACTERIZE PATIENTS WITH COVID-19 INFECTION (10,000 SUBJECTS). LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
NIAID COVID-19 ACTIV3 LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $26,150,457
COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. National Institutes of Health September 10, 2019 September 09, 2022 $0
DEVELOPMENT OF ASSAYS AND REAGENTS FOR CORONAVIRUS VACCINES BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $0
DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT EMMES CORPORATION, THE National Institutes of Health July 28, 2017 June 28, 2027 $1,671,510
CLINICAL AND NHP SAMPLE TESTING FOR SARS-COV-2 VACCINE AND OTHER BIOLOGICAL PRODUCT CANDIDATES BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $98,800
COVID-19 RELATED STUDY INVOLVING DOGS IIT RESEARCH INSTITUTE National Institutes of Health September 16, 2020 March 15, 2021 $597,893
IDT BIOLOGIKA FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID 19 IDT BIOLOGIKA GMBH National Institutes of Health May 08, 2020 May 14, 2028 $541,627
CONTRACEPTIVE CLINICAL TRIAL NETWORK -CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: EFFICACY STUDY HHSN275201300003I/HHSN27500003 REGENTS OF THE UNIVERSITY OF COLORADO, THE National Institutes of Health September 19, 2014 December 31, 2020 $25,912
NATIONAL HISTORY OF SARS-COV-2 INFECTION REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE Centers for Disease Control and Prevention June 01, 2020 November 30, 2022 $0
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID COMMUNITY ACTION AND RESEARCH ENGAGEMENT (COVID-CARE) VIGNET INC. National Institutes of Health September 14, 2020 September 13, 2021 $1,098,256
DIGITAL HEALTH SOLUTIONS FOR COVID-19: DIGITAL HEALTH PASS AND SMARTER CONTACT TRACING SOLUTIONS INTERNATIONAL BUSINESS MACHINES CORPORATION National Institutes of Health September 14, 2020 September 13, 2021 $792,019
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID-19 ONGOING MONITORING (COMMUNITY) EVIDATION HEALTH, INC. National Institutes of Health September 14, 2020 September 13, 2021 $240,000
DIGITAL HEALTH SOLUTIONS FOR COVID-19 SHEE ATIKA ENTERPRISES, LLC National Institutes of Health September 14, 2020 September 13, 2021 $922,703
DIGITAL HEALTH SOLUTIONS FOR COVID-19: PERSONALIZED ANALYTICS WEARABLE BIOSENSOR PLATFORM FOR EARLY DETECTION OF COVID-19 DECOMPENSATION PHYSIQ, INC National Institutes of Health September 14, 2020 September 13, 2021 $2,305,814
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVIDSEEKER AND COVID-19 CITIZEN SCIENCE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE National Institutes of Health September 14, 2020 September 13, 2021 $459,748
DIGITAL HEALTH SOLUTIONS FOR COVID-19: CLEAR2GO ICRYPTO, INC. National Institutes of Health September 14, 2020 September 13, 2021 $274,880
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION VANDERBILT UNIVERSITY MEDICAL CENTER National Institutes of Health September 16, 2019 September 15, 2024 $1,496,863
HHSN275201800004I - TASK ORDER 8: GENETIC ANALYSIS OF PEAS SAMPLES 2019 - REGENTS OF THE UNIVERSITY OF MINNESOTA - CAN 8473518 REGENTS OF THE UNIVERSITY OF MINNESOTA National Institutes of Health September 20, 2019 July 19, 2021 $0
HHSN275201800004I - BIOMEDICAL ASSAY LABORATORY FOR DIPHR, TASK ORDER #2: MEASUREMENT OF OPIOIDS, DIETARY FACTORS, AND GENETICS IN THE FAZST/IDEAL STUDIES - UNIVERSITY OF MINNESOTA - CAN 8473518 REGENTS OF THE UNIVERSITY OF MINNESOTA National Institutes of Health September 20, 2019 July 19, 2021 $0
HHSN275201800004I - TASK ORDER 7 SUICIDE AND MATERNAL IMMUNE ACTIVITY - REAGENTS OF THE UNIVERSITY OF MINNESOTA - CAN 8473518 REGENTS OF THE UNIVERSITY OF MINNESOTA National Institutes of Health September 20, 2019 July 19, 2021 $0
ESTABLISH A VIRTUAL NETWORK TO INVESTIGATE THE TRAJECTORY OF COVID-19-RELATED SEVERE OUTCOMES WESTAT, INC. Centers for Disease Control and Prevention May 04, 2020 September 30, 2022 $0
NIAID COVID-19 ACTIV3 LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $198,740,313
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $0
ESTABLISH A VIRTUAL NETWORK TO INVESTIGATE THE TRAJECTORY OF COVID-19-RELATED SEVERE OUTCOMES WESTAT, INC. Centers for Disease Control and Prevention May 04, 2020 September 30, 2022 $2,656,364
COVID-19: NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT DUKE UNIVERSITY National Institutes of Health December 22, 2017 December 17, 2024 $573,990
NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $68,909,533
COVID-19 VITRO TRANSCRIPTION/TRANSLATION IMMPORT THERAPEUTICS, INC. Centers for Disease Control and Prevention September 01, 2020 January 31, 2021 $72,000
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI National Institutes of Health September 10, 2019 August 04, 2025 $1,084,986
TASK AREA 5: PREPAREDNESS FOR TESTING NIAID PRIORITY VACCINES IN GENERAL SAFETY AND TOXICOLOGY STUDIES BATTELLE MEMORIAL INSTITUTE National Institutes of Health May 30, 2017 May 31, 2022 $814,926
TO EXTEND THE PERIOD OF PERFORMANCE AT NO ADDITIONAL COST, DUE TO THE TEMPORARY STOPPAGE IN OPERATIONS AS A RESULT OF THE COVID-19 QUARANTINE. GENCIRQ, INC. National Institutes of Health July 31, 2019 October 31, 2020 $0
NIAID DIR LEIDOS BIOMEDICAL RESEARCH, INC. National Institutes of Health August 31, 2020 August 30, 2024 $6,882,557
MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC UNIVERSITY OF CHICAGO, THE National Institutes of Health August 21, 2020 None $0
MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC)FOR RAPID RESPONSE TO COVID-19 PANDEMIC UNIVERSITY OF CHICAGO, THE National Institutes of Health August 21, 2020 August 20, 2022 $9,500,000
CLINICAL AND NHP SAMPLE TESTING FOR SARS-COV-2 VACCINE AND OTHER BIOLOGICAL PRODUCT CANDIDATES BATTELLE MEMORIAL INSTITUTE National Institutes of Health September 18, 2020 September 17, 2022 $1,005,452
MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC UNIVERSITY OF CHICAGO, THE National Institutes of Health August 21, 2020 None $0
MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC UNIVERSITY OF CHICAGO, THE National Institutes of Health August 21, 2020 August 20, 2022 $0
COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. National Institutes of Health September 10, 2019 September 09, 2022 $1,939,401
COVID19 - CSU/BIOMARC HUMAN CHALLENGE MATERIAL DEVELOPMENT COLORADO STATE UNIVERSITY National Institutes of Health August 17, 2020 August 16, 2021 $3,601,220
SUPPORT EAP TO FACILITATE THE USE OF HUMAN CONVALESCENT PLASMA TO TREAT HOSPITALIZED CORONAVIRUS-2 (SARS-COV-2) COVID-19 PATIENTS MAYO CLINIC Office of Assistant Secretary for Preparedness and Response - HHS May 01, 2020 April 30, 2022 $0
HHSN275201400003I/HHSN27500045 - REPOSITORY PULL FOR EAGER AND BIOCYCLE SAMPLES 2019 - FISHER BIOSERVICES - CAN 8473518 FISHER BIOSERVICES, INC. National Institutes of Health September 24, 2019 March 22, 2022 $0
HHSN275201400003I/HHSN27500036 - PULL FOR FAZST/IDEAL BIOSPECIMEN ANALYSIS 2018 - FISHER BIOSERVIES - CAN 8473518 FISHER BIOSERVICES, INC. National Institutes of Health September 24, 2019 March 22, 2022 $0
‹ Previous 1
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page